

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.63877855 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.21205120 |
| 3 | cellular response to ethanol (GO:0071361) | 4.02006369 |
| 4 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.69423345 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.69305946 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.64946258 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 3.53947647 |
| 8 | indolalkylamine metabolic process (GO:0006586) | 3.48512937 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.45002813 |
| 10 | tryptophan catabolic process (GO:0006569) | 3.41026893 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 3.41026893 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 3.41026893 |
| 13 | negative regulation of complement activation (GO:0045916) | 3.35719675 |
| 14 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.31380814 |
| 15 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.29314151 |
| 16 | regulation of memory T cell differentiation (GO:0043380) | 3.27338163 |
| 17 | tryptophan metabolic process (GO:0006568) | 3.20243252 |
| 18 | positive regulation of granulocyte differentiation (GO:0030854) | 3.11406884 |
| 19 | negative thymic T cell selection (GO:0045060) | 3.07562256 |
| 20 | negative regulation of protein activation cascade (GO:2000258) | 3.07375283 |
| 21 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.05670868 |
| 22 | negative regulation of humoral immune response (GO:0002921) | 3.04740274 |
| 23 | hepatocyte apoptotic process (GO:0097284) | 3.03539462 |
| 24 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.03346546 |
| 25 | negative T cell selection (GO:0043383) | 3.02811234 |
| 26 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.98624919 |
| 27 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.98624919 |
| 28 | establishment of protein localization to Golgi (GO:0072600) | 2.98061084 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.93795702 |
| 30 | negative regulation of cell killing (GO:0031342) | 2.93795702 |
| 31 | response to type I interferon (GO:0034340) | 2.93723139 |
| 32 | sphingoid metabolic process (GO:0046519) | 2.92275711 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91125361 |
| 34 | signal peptide processing (GO:0006465) | 2.90953702 |
| 35 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.90695827 |
| 36 | cytokine biosynthetic process (GO:0042089) | 2.90441169 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.89675811 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 2.88143034 |
| 39 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.87730260 |
| 40 | histone H3-K36 demethylation (GO:0070544) | 2.87659495 |
| 41 | type I interferon signaling pathway (GO:0060337) | 2.86882485 |
| 42 | cellular response to type I interferon (GO:0071357) | 2.86882485 |
| 43 | B cell receptor signaling pathway (GO:0050853) | 2.75810542 |
| 44 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.71516813 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.71071566 |
| 46 | phospholipid translocation (GO:0045332) | 2.70978373 |
| 47 | lipid translocation (GO:0034204) | 2.70978373 |
| 48 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.68040647 |
| 49 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.62966461 |
| 50 | protein K48-linked deubiquitination (GO:0071108) | 2.61679460 |
| 51 | tachykinin receptor signaling pathway (GO:0007217) | 2.61558389 |
| 52 | response to interleukin-15 (GO:0070672) | 2.61185623 |
| 53 | regulation of establishment of cell polarity (GO:2000114) | 2.58558262 |
| 54 | regulation of B cell differentiation (GO:0045577) | 2.58099322 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57623278 |
| 56 | kynurenine metabolic process (GO:0070189) | 2.57605111 |
| 57 | cellular response to interleukin-15 (GO:0071350) | 2.57128130 |
| 58 | cytokine metabolic process (GO:0042107) | 2.55378452 |
| 59 | cellular extravasation (GO:0045123) | 2.52349541 |
| 60 | protein K63-linked deubiquitination (GO:0070536) | 2.45079708 |
| 61 | xenobiotic catabolic process (GO:0042178) | 2.43888913 |
| 62 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.43104684 |
| 63 | positive regulation of developmental pigmentation (GO:0048087) | 2.42781272 |
| 64 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.40918524 |
| 65 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.40766371 |
| 66 | definitive hemopoiesis (GO:0060216) | 2.40686488 |
| 67 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.40417466 |
| 68 | establishment of protein localization to vacuole (GO:0072666) | 2.38458716 |
| 69 | protein targeting to vacuole (GO:0006623) | 2.38458716 |
| 70 | protein targeting to lysosome (GO:0006622) | 2.38458716 |
| 71 | protein targeting to Golgi (GO:0000042) | 2.37096723 |
| 72 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.35187558 |
| 73 | negative regulation of adaptive immune response (GO:0002820) | 2.34575194 |
| 74 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.33507362 |
| 75 | T-helper cell differentiation (GO:0042093) | 2.33507362 |
| 76 | negative regulation of mast cell activation (GO:0033004) | 2.31775068 |
| 77 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.31409303 |
| 78 | regulation of regulatory T cell differentiation (GO:0045589) | 2.30544899 |
| 79 | T cell selection (GO:0045058) | 2.30108499 |
| 80 | positive regulation of natural killer cell activation (GO:0032816) | 2.29956376 |
| 81 | interkinetic nuclear migration (GO:0022027) | 2.29001868 |
| 82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.28034244 |
| 83 | detection of molecule of bacterial origin (GO:0032490) | 2.27806109 |
| 84 | negative regulation of B cell mediated immunity (GO:0002713) | 2.27077815 |
| 85 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.27077815 |
| 86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.26505655 |
| 87 | detection of other organism (GO:0098543) | 2.23859094 |
| 88 | JAK-STAT cascade (GO:0007259) | 2.23260922 |
| 89 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.22952217 |
| 90 | iron ion import (GO:0097286) | 2.22877521 |
| 91 | detection of bacterium (GO:0016045) | 2.21459832 |
| 92 | detection of external biotic stimulus (GO:0098581) | 2.21085164 |
| 93 | positive regulation of DNA recombination (GO:0045911) | 2.21039344 |
| 94 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.16754473 |
| 95 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.16676354 |
| 96 | snRNA transcription (GO:0009301) | 2.15918940 |
| 97 | benzene-containing compound metabolic process (GO:0042537) | 2.15104831 |
| 98 | T cell migration (GO:0072678) | 2.14791807 |
| 99 | regulation of mast cell activation (GO:0033003) | 2.13363923 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 2.10243874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.26694649 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.05179837 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.29897586 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.87683506 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.62612590 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.32681895 |
| 7 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.18810024 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14805490 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06982216 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.90945768 |
| 11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87828045 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.87211268 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82075983 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81376069 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79164077 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76384663 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75721911 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75425473 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 1.73136552 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.71542135 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70570980 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.69594579 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69480774 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69183631 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66629002 |
| 26 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.66583542 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.61999673 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.61237301 |
| 29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58593101 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58285113 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57785567 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57371751 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56400408 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53559147 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52340643 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51467127 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50411831 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48358471 |
| 39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.46024557 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44737614 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.43312914 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40803905 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39034296 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38403182 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35657763 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.35559971 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.34938641 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31962955 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31610963 |
| 50 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30993356 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30063168 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29134326 |
| 53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.28892847 |
| 54 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.27144623 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24448060 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24225614 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23049446 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23049446 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.21879389 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20939222 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20554319 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.19039755 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17093598 |
| 64 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15623025 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15567925 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15368474 |
| 67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15058409 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14937724 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14246701 |
| 70 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.14021043 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13971101 |
| 72 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.13600676 |
| 73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13435950 |
| 74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12821861 |
| 75 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11815182 |
| 76 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.11663438 |
| 77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10165709 |
| 78 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09118918 |
| 79 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09015534 |
| 80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08734784 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07301761 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07232194 |
| 83 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06273143 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04769925 |
| 85 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04611762 |
| 86 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02119945 |
| 87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02002068 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01479687 |
| 89 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.01225085 |
| 90 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.00583839 |
| 91 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98405973 |
| 92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98389832 |
| 93 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97669860 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97052822 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96650429 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95366211 |
| 97 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94691390 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93975232 |
| 99 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93421015 |
| 100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93421015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 2.77700157 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.69596033 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.39689468 |
| 4 | MP0002166_altered_tumor_susceptibility | 2.38362161 |
| 5 | MP0003045_fibrosis | 2.30246922 |
| 6 | MP0009785_altered_susceptibility_to | 2.25971673 |
| 7 | MP0003195_calcinosis | 2.22732939 |
| 8 | MP0000685_abnormal_immune_system | 2.22102338 |
| 9 | MP0005671_abnormal_response_to | 2.21897211 |
| 10 | MP0003724_increased_susceptibility_to | 2.16878850 |
| 11 | MP0008057_abnormal_DNA_replication | 2.11790139 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.07366451 |
| 13 | MP0006054_spinal_hemorrhage | 2.06407699 |
| 14 | MP0001800_abnormal_humoral_immune | 2.01518893 |
| 15 | MP0005387_immune_system_phenotype | 1.94821914 |
| 16 | MP0001790_abnormal_immune_system | 1.94821914 |
| 17 | MP0006082_CNS_inflammation | 1.92641381 |
| 18 | MP0001501_abnormal_sleep_pattern | 1.87520109 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.82707270 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.77048709 |
| 21 | MP0003436_decreased_susceptibility_to | 1.76981142 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.75605643 |
| 23 | MP0005310_abnormal_salivary_gland | 1.69248172 |
| 24 | MP0002009_preneoplasia | 1.67736349 |
| 25 | MP0002723_abnormal_immune_serum | 1.67312972 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.66596645 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.65999848 |
| 28 | MP0005025_abnormal_response_to | 1.64165154 |
| 29 | MP0003252_abnormal_bile_duct | 1.64022586 |
| 30 | MP0002419_abnormal_innate_immunity | 1.62704434 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.61647100 |
| 32 | MP0004381_abnormal_hair_follicle | 1.59830883 |
| 33 | MP0009278_abnormal_bone_marrow | 1.57942165 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.55980747 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.53937958 |
| 36 | MP0001873_stomach_inflammation | 1.53454008 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.52150543 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.51895360 |
| 39 | MP0002006_tumorigenesis | 1.50486368 |
| 40 | MP0002405_respiratory_system_inflammati | 1.50218892 |
| 41 | MP0001819_abnormal_immune_cell | 1.50139618 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.49034903 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.49034903 |
| 44 | MP0000371_diluted_coat_color | 1.47525368 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.45374699 |
| 46 | MP0002168_other_aberrant_phenotype | 1.41167460 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.39888529 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.39134157 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.35943667 |
| 50 | MP0009840_abnormal_foam_cell | 1.34400411 |
| 51 | MP0009764_decreased_sensitivity_to | 1.32032433 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.31836305 |
| 53 | MP0005451_abnormal_body_composition | 1.29408860 |
| 54 | MP0004947_skin_inflammation | 1.29346503 |
| 55 | MP0000427_abnormal_hair_cycle | 1.28706029 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.26602886 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.25742852 |
| 58 | MP0002398_abnormal_bone_marrow | 1.22042450 |
| 59 | MP0000716_abnormal_immune_system | 1.21675091 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.20709705 |
| 61 | MP0005164_abnormal_response_to | 1.19171512 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.16881977 |
| 63 | MP0005360_urolithiasis | 1.16448708 |
| 64 | MP0002693_abnormal_pancreas_physiology | 1.16133074 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.15641726 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.14825582 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.13843279 |
| 68 | MP0004883_abnormal_blood_vessel | 1.13430312 |
| 69 | MP0008469_abnormal_protein_level | 1.08816506 |
| 70 | MP0002722_abnormal_immune_system | 1.04909224 |
| 71 | MP0001851_eye_inflammation | 1.04805898 |
| 72 | MP0004043_abnormal_pH_regulation | 1.03389626 |
| 73 | MP0002933_joint_inflammation | 1.01056906 |
| 74 | MP0009780_abnormal_chondrocyte_physiolo | 1.00476266 |
| 75 | MP0005647_abnormal_sex_gland | 0.99291276 |
| 76 | MP0005365_abnormal_bile_salt | 0.98371823 |
| 77 | MP0003303_peritoneal_inflammation | 0.94435260 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.91927302 |
| 79 | MP0002429_abnormal_blood_cell | 0.90632941 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.89037168 |
| 81 | MP0003866_abnormal_defecation | 0.88931974 |
| 82 | MP0000383_abnormal_hair_follicle | 0.87980560 |
| 83 | MP0005275_abnormal_skin_tensile | 0.86053380 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.85439006 |
| 85 | MP0002132_abnormal_respiratory_system | 0.84843443 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.84651353 |
| 87 | MP0000249_abnormal_blood_vessel | 0.83045155 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 0.82250480 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.81656717 |
| 90 | MP0005085_abnormal_gallbladder_physiolo | 0.81389714 |
| 91 | MP0003868_abnormal_feces_composition | 0.75135462 |
| 92 | MP0010678_abnormal_skin_adnexa | 0.74792142 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.74011378 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.72376503 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.71992362 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.70629369 |
| 97 | MP0002971_abnormal_brown_adipose | 0.70410583 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 0.70329707 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.70188659 |
| 100 | MP0005670_abnormal_white_adipose | 0.68766639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 4.48890109 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 4.42962303 |
| 3 | Optic neuritis (HP:0100653) | 4.42962303 |
| 4 | Myositis (HP:0100614) | 4.38195932 |
| 5 | Keratoconjunctivitis sicca (HP:0001097) | 3.41845843 |
| 6 | Keratoconjunctivitis (HP:0001096) | 3.33254834 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.19504057 |
| 8 | T lymphocytopenia (HP:0005403) | 3.09664435 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.09638048 |
| 10 | Autoimmune hemolytic anemia (HP:0001890) | 3.06098971 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.03734726 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 2.94615988 |
| 13 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.87857369 |
| 14 | Hypoproteinemia (HP:0003075) | 2.78678812 |
| 15 | Recurrent abscess formation (HP:0002722) | 2.74063727 |
| 16 | Abnormality of B cell number (HP:0010975) | 2.73397236 |
| 17 | Attenuation of retinal blood vessels (HP:0007843) | 2.73163031 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 2.72060666 |
| 19 | Pulmonary infiltrates (HP:0002113) | 2.71763453 |
| 20 | Chronic diarrhea (HP:0002028) | 2.70972754 |
| 21 | Hematochezia (HP:0002573) | 2.70218177 |
| 22 | Hemoptysis (HP:0002105) | 2.64232841 |
| 23 | Clumsiness (HP:0002312) | 2.53260248 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.52407292 |
| 25 | Hyperventilation (HP:0002883) | 2.51828336 |
| 26 | Vasculitis (HP:0002633) | 2.50413055 |
| 27 | Spontaneous hematomas (HP:0007420) | 2.46305378 |
| 28 | Eczematoid dermatitis (HP:0000976) | 2.44441327 |
| 29 | Thyroiditis (HP:0100646) | 2.41806200 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.41415788 |
| 31 | Encephalitis (HP:0002383) | 2.40158743 |
| 32 | Stomatitis (HP:0010280) | 2.39726028 |
| 33 | Arterial thrombosis (HP:0004420) | 2.39452348 |
| 34 | Eosinophilia (HP:0001880) | 2.39127193 |
| 35 | Anorexia (HP:0002039) | 2.38945288 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.35503208 |
| 37 | Keratitis (HP:0000491) | 2.35395286 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.34496087 |
| 39 | Genetic anticipation (HP:0003743) | 2.33152586 |
| 40 | Fair hair (HP:0002286) | 2.32731478 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29845002 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29845002 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29845002 |
| 44 | Mucopolysacchariduria (HP:0008155) | 2.29832956 |
| 45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29832956 |
| 46 | Gingival bleeding (HP:0000225) | 2.28205777 |
| 47 | Pustule (HP:0200039) | 2.25555766 |
| 48 | Ketoacidosis (HP:0001993) | 2.25474043 |
| 49 | Portal hypertension (HP:0001409) | 2.23231218 |
| 50 | Meningitis (HP:0001287) | 2.22412623 |
| 51 | Abnormality of T cells (HP:0002843) | 2.22162353 |
| 52 | Epistaxis (HP:0000421) | 2.22063762 |
| 53 | Facial diplegia (HP:0001349) | 2.20463806 |
| 54 | Gangrene (HP:0100758) | 2.17958589 |
| 55 | Abnormality of the hepatic vasculature (HP:0006707) | 2.17915550 |
| 56 | Generalized hypopigmentation of hair (HP:0011358) | 2.17147892 |
| 57 | Granulocytopenia (HP:0001913) | 2.16504568 |
| 58 | Constricted visual fields (HP:0001133) | 2.16337795 |
| 59 | Recurrent viral infections (HP:0004429) | 2.15619901 |
| 60 | Central scotoma (HP:0000603) | 2.15077817 |
| 61 | Albinism (HP:0001022) | 2.14011529 |
| 62 | B lymphocytopenia (HP:0010976) | 2.13310663 |
| 63 | Pulmonary embolism (HP:0002204) | 2.12980054 |
| 64 | Abnormality of eosinophils (HP:0001879) | 2.12375912 |
| 65 | Protruding tongue (HP:0010808) | 2.11990649 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.11911308 |
| 67 | Prostate neoplasm (HP:0100787) | 2.11584995 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.10628366 |
| 69 | Congenital sensorineural hearing impairment (HP:0008527) | 2.10036128 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.09756005 |
| 71 | Recurrent skin infections (HP:0001581) | 2.05166338 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.04063632 |
| 73 | Recurrent bronchitis (HP:0002837) | 1.99668105 |
| 74 | Abnormality of the pleura (HP:0002103) | 1.95829768 |
| 75 | Colitis (HP:0002583) | 1.95369469 |
| 76 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.93229558 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 1.91239766 |
| 78 | Abnormality of the pericardium (HP:0001697) | 1.90782924 |
| 79 | Joint swelling (HP:0001386) | 1.90042990 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 1.89493803 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 1.87843110 |
| 82 | Dysmetric saccades (HP:0000641) | 1.87675053 |
| 83 | Leukocytosis (HP:0001974) | 1.87535059 |
| 84 | Widely spaced teeth (HP:0000687) | 1.84959190 |
| 85 | Tubulointerstitial fibrosis (HP:0005576) | 1.84643864 |
| 86 | Abnormality of the prostate (HP:0008775) | 1.84016879 |
| 87 | Increased CSF protein (HP:0002922) | 1.83800452 |
| 88 | Abnormality of proline metabolism (HP:0010907) | 1.83142424 |
| 89 | Hydroxyprolinuria (HP:0003080) | 1.83142424 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.82945613 |
| 91 | Stomach cancer (HP:0012126) | 1.82441690 |
| 92 | Pancreatic cysts (HP:0001737) | 1.78121105 |
| 93 | Severe combined immunodeficiency (HP:0004430) | 1.77337104 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 1.76966367 |
| 95 | Absent speech (HP:0001344) | 1.74377482 |
| 96 | Progressive visual loss (HP:0000529) | 1.73260741 |
| 97 | Acne (HP:0001061) | 1.73192503 |
| 98 | Chest pain (HP:0100749) | 1.73147943 |
| 99 | Keratoconus (HP:0000563) | 1.72927965 |
| 100 | Increased corneal curvature (HP:0100692) | 1.72927965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.54719246 |
| 2 | MAP2K6 | 2.29568304 |
| 3 | TYK2 | 2.21342983 |
| 4 | TAOK3 | 2.20037611 |
| 5 | PIK3CG | 2.16249021 |
| 6 | MAP3K14 | 2.14338889 |
| 7 | ADRBK2 | 1.98641716 |
| 8 | MAP4K1 | 1.97901157 |
| 9 | JAK1 | 1.92459221 |
| 10 | NLK | 1.91436913 |
| 11 | AKT3 | 1.91194492 |
| 12 | ERN1 | 1.89144135 |
| 13 | TEC | 1.78963283 |
| 14 | TXK | 1.77366638 |
| 15 | TGFBR2 | 1.75530455 |
| 16 | IRAK1 | 1.73257699 |
| 17 | TNK2 | 1.72812390 |
| 18 | KIT | 1.68608254 |
| 19 | TRPM7 | 1.65074847 |
| 20 | RIPK4 | 1.60219739 |
| 21 | FGFR3 | 1.57905948 |
| 22 | EPHA3 | 1.55640653 |
| 23 | IKBKB | 1.45250267 |
| 24 | IKBKE | 1.44764999 |
| 25 | MAP4K2 | 1.44546114 |
| 26 | INSRR | 1.42021355 |
| 27 | ACVR1B | 1.41938916 |
| 28 | ITK | 1.37846979 |
| 29 | JAK3 | 1.32586383 |
| 30 | BLK | 1.28281343 |
| 31 | FER | 1.27488028 |
| 32 | BTK | 1.25129159 |
| 33 | EIF2AK3 | 1.22252263 |
| 34 | MAP3K2 | 1.15208949 |
| 35 | SYK | 1.09390154 |
| 36 | PTK2B | 1.07668393 |
| 37 | CSF1R | 1.04176925 |
| 38 | MAPKAPK3 | 1.00615946 |
| 39 | HCK | 0.97421779 |
| 40 | TBK1 | 0.94122009 |
| 41 | MAPK7 | 0.93968266 |
| 42 | GRK1 | 0.92062737 |
| 43 | MAP3K3 | 0.88497384 |
| 44 | LATS1 | 0.88321077 |
| 45 | MAPK11 | 0.87953069 |
| 46 | ADRBK1 | 0.86467732 |
| 47 | CAMKK2 | 0.86420158 |
| 48 | JAK2 | 0.85656225 |
| 49 | BMPR1B | 0.85034881 |
| 50 | LCK | 0.84940563 |
| 51 | MAP3K7 | 0.84556031 |
| 52 | PDK1 | 0.83895844 |
| 53 | PRKD2 | 0.83720938 |
| 54 | MARK3 | 0.83362622 |
| 55 | CSK | 0.82881622 |
| 56 | NUAK1 | 0.81659427 |
| 57 | FES | 0.80560994 |
| 58 | LYN | 0.80180036 |
| 59 | ZAP70 | 0.79670006 |
| 60 | STK10 | 0.79558880 |
| 61 | GRK6 | 0.77546311 |
| 62 | HIPK2 | 0.76962596 |
| 63 | YES1 | 0.74941408 |
| 64 | FGFR4 | 0.74128504 |
| 65 | BMPR2 | 0.73753890 |
| 66 | IRAK4 | 0.72502297 |
| 67 | PRKAA2 | 0.72439176 |
| 68 | SGK2 | 0.71639326 |
| 69 | EPHB1 | 0.71505719 |
| 70 | STK38 | 0.71298330 |
| 71 | MELK | 0.71230379 |
| 72 | MAP3K13 | 0.71228653 |
| 73 | CHUK | 0.69436396 |
| 74 | MAP2K3 | 0.67940160 |
| 75 | PRKCQ | 0.65749893 |
| 76 | OXSR1 | 0.65518253 |
| 77 | CDC42BPA | 0.62076608 |
| 78 | MAPK13 | 0.59905385 |
| 79 | NEK9 | 0.59820404 |
| 80 | PDPK1 | 0.54911801 |
| 81 | MST4 | 0.53718009 |
| 82 | PRKCH | 0.51668481 |
| 83 | PRKCE | 0.49275725 |
| 84 | STK3 | 0.48945362 |
| 85 | CDK12 | 0.47972848 |
| 86 | ABL1 | 0.47092601 |
| 87 | SGK3 | 0.45511342 |
| 88 | STK38L | 0.44927068 |
| 89 | DAPK2 | 0.42933951 |
| 90 | MAP2K2 | 0.39980002 |
| 91 | MAPKAPK2 | 0.38963550 |
| 92 | PDGFRB | 0.38128763 |
| 93 | MAP3K1 | 0.35752099 |
| 94 | RPS6KB1 | 0.35211816 |
| 95 | EEF2K | 0.34356130 |
| 96 | MAPK3 | 0.33681513 |
| 97 | IGF1R | 0.33502257 |
| 98 | NTRK3 | 0.32174230 |
| 99 | MATK | 0.31741185 |
| 100 | MYLK | 0.31383776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24114131 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.14486774 |
| 3 | ABC transporters_Homo sapiens_hsa02010 | 2.09837896 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96509685 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 1.87427797 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84596809 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77729717 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75000874 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70570720 |
| 10 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66552437 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51968327 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51082618 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49525351 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.43978962 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.43936802 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43191748 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.40395983 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.38680137 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.38171061 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.33635405 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33579899 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.33168812 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32110379 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30276035 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28319833 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.27392338 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26559307 |
| 28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24655412 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23228503 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20621806 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19299338 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19041832 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18337155 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13756258 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12884431 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12327560 |
| 37 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05335437 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.04312105 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03419020 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02127506 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.01762985 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98526575 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98355129 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97982288 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.97891754 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97784241 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.92893485 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.92874515 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92312175 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.91495811 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91339050 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86928381 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 0.86462792 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86257545 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84245362 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83368399 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80775930 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80314182 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80039162 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79525040 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75765795 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.74581363 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73645695 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72305944 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.70932428 |
| 66 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70885233 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.70061194 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69421743 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.68999201 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68921952 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68415141 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67524421 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67122089 |
| 74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67097723 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.66897884 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65243574 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65038769 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63890204 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63717257 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63653712 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63375604 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58455541 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57830059 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57672816 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57575162 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57491233 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.57063131 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54737975 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54446900 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54104460 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53950690 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52884793 |
| 93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51949698 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51894115 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.50223213 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50135131 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49617412 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48922524 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48183335 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47206496 |

